StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pacira Pharmaceuticals (PCRX) PT Raised to $47 at BMO Capital
November 2, 2018 8:13 AM
BMO Capital analyst Gary Nachman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Pacira Pharmaceuticals (PCRX) PT Raised to $46 at Mizuho Securities Following 3Q
November 5, 2018 7:16 AM